Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 8, 2008 - Issue 6
Submit an article Journal homepage
79
Views
4
CrossRef citations to date
0
Altmetric
Drug Profile

Palivizumab in preventing respiratory syncytial virus-related hospitalization in high-risk infants

Bernhard Resch Research Unit for Neonatal Infectious Diseases and Epidemiology, Division of Neonatology, Pediatric Department, Medical University Graz, Austria. [email protected]
Pages 529-538 | Published online: 09 Jan 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Bernhard Resch. (2017) Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection. Human Vaccines & Immunotherapeutics 13:9, pages 2138-2149.
Read now

Articles from other publishers (3)

Bernhard Resch. (2014) Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis. The Open Microbiology Journal 8:1, pages 71-77.
Crossref
Bernhard Resch & Ina Michel-Behnke. (2013) Respiratory syncytial virus infections in infants and children with congenital heart disease. Current Opinion in Cardiology 28:2, pages 85-91.
Crossref
Bernhard Resch, Constanze Sommer, Mark J. C. Nuijten, Susanne Seidinger, Evelyn Walter, Vera Schoellbauer & Wilhelm D. Mueller. (2012) Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus Infection in High-risk Children, Based on Long-term Epidemiologic Data From Austria. Pediatric Infectious Disease Journal 31:1, pages e1-e8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.